Multimodal imaging in the characterization of tumors to assess tumor aggressiveness, diagnostic work-up and treatment response evaluation in prostate cancer, cervical cancer, breast cancer, sarcomas, spinal metastases, neuroendocrine tumors, GISTs, colorectal cancers, liver malignancies, multiple myeloma and lymphoma
Characterization of vascular inflammation inclusive vulnerability in atherosclerosis, treatment selection and treatment response evaluation using PET, MRI and US
Detection of inflammatory disease and treatment response evaluations using different imaging modalities and PET tracers
Characterize pituritary microadenomas, remnant adenomas following surgery and hypophysitis by the use of different MRI and PET techniques
Radio-immunotherapy for treatment of relapsed CD37+ non-Hodgkin lymphoma, novel α-emitting radionuclide therapies and Selective Internal Radiation Therapy (SIRT) with SIR-Spheres in liver malignancies
Amyloid imaging by 18F-Flutemetamol PET/CT –clinical value and quantitative reference levels
Ultrasound-guided percutaneous ethanol injection treatment in patients with metastatic lymph nodes from thyroid carcinoma
Development of new biomarkers using radiomics and artificial intelligence (AI) for the characterization of tumor heterogeneity and disease patterns
Recent publications
Langen Stokmo H, Aly M, Bowitz Lothe IM, Borja AJ, Mehdizadeh Seraj S, Ghorpade R, Miao X, Hjortland GO, Malinen E, Sorbye H, Werner TJ, Alavi A, Revheim ME(2022) Volumetric parameters from [18 F]FDG PET/CT predicts survival in patients with high-grade gastroenteropancreatic neuroendocrine neoplasms J Neuroendocrinol, e13170(in press) DOI 10.1111/jne.13170, PubMed 35729738
Stenberg VY, Tornes AJK, Nilsen HR, Revheim ME, Bruland ØS, Larsen RH, Juzeniene A(2022) Factors Influencing the Therapeutic Efficacy of the PSMA Targeting Radioligand 212Pb-NG001 Cancers (Basel), 14(11) DOI 10.3390/cancers14112784, PubMed 35681766
Borja AJ, Saini J, Raynor WY, Ayubcha C, Werner TJ, Alavi A, Revheim ME, Nagaraj C(2022) Role of Molecular Imaging with PET/MR Imaging in the Diagnosis and Management of Brain Tumors PET Clin, 17(3), 431-451 DOI 10.1016/j.cpet.2022.03.002, PubMed 35662494